Results of autologous stem cell transplant in multiple myeloma patients with renal failure-Reference-Cited by-同舟云学术

Results of autologous stem cell transplant in multiple myeloma patients with renal failure

Published:2001-09 Issue:4 Volume:114 Page:822-829
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Badros Ashraf,Barlogie Bart,Siegel Eric,Roberts Jennifer,Langmaid Candi,Zangari Maurizio,Desikan Raman,Shaver Mary Jo,Fassas Athanasios,McConnell Scott,Muwalla Firas,Barri Yousri,Anaissie Elias,Munshi Nikhil,Tricot Guido

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.03033.x/fullpdf

Reference45 articles.

1. Renal failure in multiple myeloma. Pathogenesis and prognostic implications;Alexanian;Archives of Internal Medicine,1990

2. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;New England Journal of Medicine,1996

3. No correlation between response and survival in patients with multiple myeloma treated with vincristine, melphalan, cyclophosphamide, and prednisone;Baldini;Cancer,1991

4. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency;Ballester;Bone Marrow Transplantation,1997

5. Total therapy with tandem transplants for newly diagnosed multiple myeloma;Barlogie;Blood,1999

Cited by 256 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modest survival benefits of autologous stem cell transplantation in multiple myeloma with renal impairment: a critical appraisal of the pre-antibody era;Clinical and Experimental Medicine;2024-09-09

2. Assessing Outcomes in Patients With Multiple Myeloma Postautologous Stem Cell Transplantation: Contrasting the Effects of Melphalan Dosages at 200 mg/m2 versus 140 mg/m2;Clinical Lymphoma Myeloma and Leukemia;2024-09

3. Personalized Treatment of Multiple Myeloma in Frail Patients;Current Oncology Reports;2024-05-18

4. Kidney function in newly diagnosed myeloma patients: factors associated with kidney impairment and recovery;2024-04-16

5. Outcomes of Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving Salvage Cytotoxic Therapy with Supportive Stem Cell Boost;Current Stem Cell Research & Therapy;2024-04-03